BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/26/2024 8:53:40 AM | Browse: 372 | Download: 918
 |
Received |
|
2023-12-24 05:12 |
|
Peer-Review Started |
|
2023-12-24 05:12 |
|
First Decision by Editorial Office Director |
|
2024-01-19 01:02 |
|
Return for Revision |
|
2024-01-19 01:02 |
|
Revised |
|
2024-01-24 01:06 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-01 01:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-01 02:01 |
|
Articles in Press |
|
2024-04-01 02:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-04-22 00:46 |
|
Publish the Manuscript Online |
|
2024-04-26 08:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Masaya Iwamuro, Seiji Kawano and Motoyuki Otsuka |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Masaya Iwamuro, MD, PhD, Assistant Professor, Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-Ku, Okayama 700-8558, Japan. pr145h2k@okayama-u.ac.jp |
| Key Words |
Diagnosis; Esophagogastroduodenoscopy; Non-neoplastic lesions; Esophageal lesions; Gastric lesions; Duodenal lesions |
| Core Tip |
Various lesions associated with medication use are detected during esophagogastroduodenoscopy, including pill-induced esophagitis, desquamative esophagitis, deteriorating gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet-induced gastric lesions, immune-related adverse event (irAE) gastritis, olmesartan-associated sprue-like enteropathy, duodenal pseudomelanosis, and lanthanum deposition. Endoscopists must diagnose these mucosal alterations by acquiring pertinent knowledge regarding medication-induced lesions, concomitant with inquiries concerning patient medication history. |
| Publish Date |
2024-04-26 08:53 |
| Citation |
Iwamuro M, Kawano S, Otsuka M. Drug-induced mucosal alterations observed during esophagogastroduodenoscopy. World J Gastroenterol 2024; 30(16): 2220-2232 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i16/2220.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i16.2220 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
